Medeon Biodesign (ROCO:6499) Additional Paid-In Capital : NT$1,339.2 Mil(As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Additional Paid-In Capital?

Medeon Biodesign's quarterly additional paid-in capital stayed the same from Jun. 2023 (NT$1,340.7 Mil) to Sep. 2023 (NT$1,340.7 Mil) and stayed the same from Sep. 2023 (NT$1,340.7 Mil) to Mar. 2024 (NT$1,339.2 Mil).

Medeon Biodesign's annual additional paid-in capital declined from Dec. 2020 (NT$1,933.1 Mil) to Dec. 2021 (NT$1,349.3 Mil) and declined from Dec. 2021 (NT$1,349.3 Mil) to Dec. 2022 (NT$1,343.8 Mil).

Medeon Biodesign Additional Paid-In Capital Historical Data

The historical data trend for Medeon Biodesign's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Additional Paid-In Capital Chart

Medeon Biodesign Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

1,300.63

1,673.95

1,933.08

1,349.26

1,343.81

Medeon Biodesign Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,343.81	1,349.41	1,340.71	1,340.71	1,339.21

Medeon Biodesign Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Medeon Biodesign Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Medeon Biodesign's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Medeon Biodesign (ROCO:6499) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170

Website

http://www.medeonbio.com

Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign (ROCO:6499) Headlines

No Headlines